tyrosine has been researched along with Diabetic Glomerulosclerosis in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.86) | 18.7374 |
| 1990's | 2 (5.71) | 18.2507 |
| 2000's | 18 (51.43) | 29.6817 |
| 2010's | 13 (37.14) | 24.3611 |
| 2020's | 1 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, ZZ; Feng, XF; Li, J; Luo, HH; Sun, XY; Yang, X | 1 |
| Cao, Y; Cheng, QP; Lv, XF; Sun, JM; Zhang, XG; Zhang, YQ | 1 |
| Li, XY; Long, HB; Niu, HX; Wang, M; Wang, YJ; Xu, ZZ; Zhou, WD; Zhu, Y | 1 |
| Guan, GJ; Liu, G; Liu, XC; Lv, SS; Sun, LN; Yang, ZY | 1 |
| An, ZM; Dong, XG; Guo, Y; Qin, T; Zhou, JL | 1 |
| Chan, LY; Lai, KN; Lan, HY; Leung, JC; Li, RX; Tang, SC; Wong, DW; Wu, HJ; Yam, I; Yiu, WH | 1 |
| Ji, L; Li, L; Liu, R; Liu, X; Mu, S; Sui, M; Wang, M; Xie, R; Zou, C | 1 |
| Bierhaus, A; Bozorgmehr, F; Dugi, K; Hamann, A; Humpert, PM; Ibrahim, Y; Kientsch-Engels, R; Kukudov, G; Morcos, M; Nawroth, PP; Oikomonou, D; Pfisterer, F; Rudofsky, G; Sayed, AA; Schlotterer, A; Schneider, J; Schwenger, V; van der Woude, F; Yard, B; Zeier, M | 1 |
| Higo, S; Jiang, QY; Kasuga, M; Kitazawa, R; Kitazawa, S; Miyata, S | 1 |
| Ihm, CG; Jeong, KH; Lee, SH; Lee, TW; Lim, SJ; Moon, JY | 1 |
| Hashimoto, T; Hirawa, N; Imai, N; Ishigami, T; Kihara, M; Kitamura, H; Kiuchi, Y; Nomura, K; Tamura, K; Toya, Y; Umemura, S; Yasuzaki, H; Yoshida, S | 1 |
| Duan, H; Li, Y; Liu, H; Liu, Q; Liu, S; Shi, Y; Wang, H; Wang, XM | 1 |
| Feng, W; Hua, P; Jaimes, EA; Ji, S; Raij, L | 1 |
| Chew, P; Cooper, ME; Coughlan, MT; de Haan, JB; Jandeleit-Dahm, KA; Pete, J; Rosenfeldt, F; Stefanovic, N; Thomas, MC; Yuen, DY | 1 |
| Adaikalakoteswari, A; Parving, HH; Rabbani, N; Rossing, K; Rossing, P; Tarnow, L; Thornalley, PJ | 1 |
| Fujishima, H; Fujita, H; Komatsu, K; Morii, T; Narita, T; Sakamoto, T; Takahashi, T; Yamada, Y | 1 |
| Fenoy, FJ; Hernandez, I; Li Volti, G; Lopez, B; Perez, C; Rodriguez, F; Salom, MG; Stec, DE | 1 |
| Ahmad, A; Aloisi, C; Catania, MA; Cuzzocrea, S; Di Paola, R; Esposito, E; Italiano, D; Mazzon, E; Mondello, P; Mondello, S | 1 |
| Dang, H; Kamat, A; Yeh, CK; Zhang, BX; Zhang, HM | 1 |
| Koo, JR; Vaziri, ND | 1 |
| Burns, WC; Cooper, ME; Forbes, JM; Founds, HW; Jerums, G; Thallas, V; Thomas, MC | 1 |
| Arakawa, S; Fujimoto, S; Haruna, Y; Horike, H; Kashihara, N; Komai, N; Makino, H; Sasaki, T; Satoh, M; Tsujioka, K | 1 |
| Mabley, JG; Obrosova, IG; Pacher, P; Szabó, C | 1 |
| Kó Szegi, T; Kocsis, B; Laczy, B; Markó, L; Matus, Z; Mazák, I; Mohás, M; Molnár, GA; Nagy, J; Tamaskó, M; Wagner, L; Wagner, Z; Wittmann, I | 1 |
| Gohda, T; Gu, L; Hagiwara, S; Horikoshi, S; Kaneko, S; Matsumoto, M; Nakamura, S; Qian, J; Tanimoto, M; Tomino, Y; Zhang, M | 1 |
| Aoki, T; Gohda, T; Hagiwara, S; Horikoshi, S; Ito, T; Kaneko, S; Matsumoto, M; Murakoshi, M; Tanimoto, M; Tomino, Y; Yamada, K | 1 |
| Rahbar, S | 1 |
| Biswas, SK; de Faria, JB; Peixoto, EB; Souza, DS | 1 |
| Aoki, T; Gohda, T; Horikoshi, S; Kaneko, S; Matsumoto, M; Murakoshi, M; Tanimoto, M; Tomino, Y; Yamada, K; Yamazaki, T | 1 |
| Abboud, HE; Biswas, P; Choudhury, GG; Fouqueray, B; Grandaliano, G; Wenzel, UO | 1 |
| Haneda, M; Kikkawa, R; Shikano, T; Togawa, M | 1 |
| Dodd, SM; Nott, CA; Thuraisingham, RC; Yaqoob, MM | 1 |
| Abboud, HE; Choudhury, GG; Duch, J; Duraisamy, S; Faulkner, JL; Feliers, D; Kasinath, BS; Lee, AV | 1 |
| Fujita, T; Goto, A; Onozato, ML; Tojo, A; Wilcox, CS | 1 |
| Ashby, J; Cochran, C; Gorman, MA; Gupta, V; Liepa, GU; Long, DL; Parker, TF | 1 |
1 review(s) available for tyrosine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.
Topics: Animals; Cardiomyopathies; Diabetes Complications; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Endothelium, Vascular; Humans; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Poly(ADP-ribose) Polymerases; Superoxides; Tyrosine | 2005 |
4 trial(s) available for tyrosine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Blood Glucose; Deoxyguanosine; Diabetic Nephropathies; Female; Glutathione; Hemoglobins; Humans; Insulin; Insulin Infusion Systems; Interleukin-6; Male; Middle Aged; Oxidative Stress; Superoxide Dismutase; Tyrosine | 2018 |
Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria.
Topics: Albuminuria; Amino Acids; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Bendroflumethiazide; Biomarkers; Biphenyl Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Female; Glycation End Products, Advanced; Glycosylation; Humans; Hypertension; Irbesartan; Male; Oxidative Stress; Tetrazoles; Tyrosine | 2012 |
Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Benzimidazoles; Benzoates; Cross-Over Studies; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Japan; Losartan; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Superoxide Dismutase; Telmisartan; Tyrosine | 2011 |
Effect of aspartame on plasma amino acid profiles of diabetic patients with chronic renal failure.
Topics: Amino Acids; Aspartame; Diabetic Nephropathies; Dipeptides; Female; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Phenylalanine; Renal Dialysis; Tyrosine | 1989 |
30 other study(ies) available for tyrosine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Plasma phenylalanine and tyrosine and their interactions with diabetic nephropathy for risk of diabetic retinopathy in type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Phenylalanine; Tyrosine | 2020 |
[Effect of nitrotyrosine on renal expressions of NF-κB, MCP-1 and TGF-β1 in rats with diabetic nephropathy].
Topics: Animals; Chemokine CCL2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Tyrosine | 2013 |
Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14 phosphorylation influenced TLR4 activation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Caveolin 1; Cells, Cultured; Curcumin; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, Diabetic; Humans; Kidney; Male; Mutation; Phosphorylation; Podocytes; Protein Engineering; Rats; Rats, Wistar; Toll-Like Receptor 4; Tyrosine | 2014 |
Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy.
Topics: Animals; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Kidney; Malondialdehyde; Oxidative Stress; Pentoxifylline; Rats; Streptozocin; Superoxide Dismutase; Tyrosine | 2015 |
Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress.
Topics: Animals; Diabetic Nephropathies; Fibrosis; Gene Transfer Techniques; Genetic Therapy; Kallikreins; Kidney; Kidney Function Tests; Male; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidase 4; NADPH Oxidases; Neovascularization, Pathologic; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Serpins; Transforming Growth Factor beta; Tyrosine; Vascular Endothelial Growth Factor A | 2016 |
Effect of the oral iron chelator deferiprone in diabetic nephropathy rats.
Topics: Administration, Oral; Animals; Blotting, Western; Chemokine CCL2; Cyclooxygenase 2; Deferiprone; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Carbohydrates; Dose-Response Relationship, Drug; Gene Expression; Immunohistochemistry; Iron Chelating Agents; Kidney; Male; Matrix Metalloproteinase 9; Microscopy, Electron, Transmission; NF-kappa B; Protective Agents; Pyridones; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Tissue Inhibitor of Metalloproteinase-1; Tyrosine | 2017 |
Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.
Topics: Angiotensin II; Cell Nucleus; Cells, Cultured; Diabetic Nephropathies; Epithelial Cells; Gene Expression; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Kidney Tubules, Proximal; NF-kappa B; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Rosiglitazone; Thiazolidinediones; Tyrosine | 2008 |
Taurine administration after appearance of proteinuria retards progression of diabetic nephropathy in rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Biomarkers; Blood Glucose; Body Weight; Deoxyguanosine; Diabetic Nephropathies; Disease Progression; Glycated Hemoglobin; Immunohistochemistry; Male; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Taurine; Tyrosine | 2008 |
Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Blotting, Western; Chemokine CCL2; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Immunohistochemistry; Inflammation Mediators; Kidney; Male; Nephritis; Nitric Oxide Synthase Type II; Oxidative Stress; Piperazines; Purines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sildenafil Citrate; Streptozocin; Sulfones; Tyrosine; Vasodilator Agents | 2009 |
Urinary oxidative stress markers closely reflect the efficacy of candesartan treatment for diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Deoxyguanosine; Diabetes Mellitus; Diabetic Nephropathies; Dinoprost; Disease Models, Animal; Hydralazine; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Tetrazoles; Treatment Outcome; Tyrosine | 2009 |
Peroxynitrite mediates glomerular lesion of diabetic rat via JAK/STAT signaling pathway.
Topics: Animals; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Immunohistochemistry; Janus Kinase 2; Kidney Glomerulus; Male; Microscopy, Electron, Transmission; Peroxynitrous Acid; Phosphorylation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Transforming Growth Factor beta; Tyrosine; Uric Acid | 2009 |
Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers.
Topics: Animals; Blood Glucose; Blood Pressure; Cells, Cultured; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Humans; Kidney Glomerulus; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; NADPH Oxidase 4; NADPH Oxidases; Nicotine; Nicotinic Agonists; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Smoking; Tyrosine | 2010 |
Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse.
Topics: Aldehydes; Animals; Antioxidants; Apolipoproteins E; Atherosclerosis; Azoles; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Isoindoles; Kidney; Male; Mice; Mice, Knockout; Organoselenium Compounds; Reactive Oxygen Species; Tyrosine; Vascular Cell Adhesion Molecule-1 | 2010 |
Chronic tempol treatment attenuates the renal hemodynamic effects induced by a heme oxygenase inhibitor in streptozotocin diabetic rats.
Topics: Animals; Antioxidants; Boranes; Carbon Monoxide; Carbonates; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Hemodynamics; Kidney; Male; Metalloporphyrins; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Renal Circulation; Spin Labels; Time Factors; Tyrosine; Vasoconstriction; Vasodilation | 2011 |
Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: a comparison with n-acetylcysteine.
Topics: Acetophenones; Acetylcysteine; Acute-Phase Proteins; Animals; Apoptosis; Contrast Media; Cytosine; Diabetic Nephropathies; Enzyme Activation; Enzyme Inhibitors; Glutathione Transferase; Iopamidol; Isoenzymes; Kidney Glomerulus; Lipocalin-2; Lipocalins; Male; NADPH Oxidases; Poly(ADP-ribose) Polymerases; Potassium; Proto-Oncogene Proteins; Rats; Rats, Wistar; Sodium; Time Factors; Tyrosine | 2012 |
Geldanamycin derivative ameliorates high fat diet-induced renal failure in diabetes.
Topics: Animals; Benzoquinones; Calcium; Diabetic Nephropathies; Diet, High-Fat; Disease Models, Animal; HSP90 Heat-Shock Proteins; Kaplan-Meier Estimate; Kidney Function Tests; Kidney Glomerulus; Kidney Tubules; Lactams, Macrocyclic; Male; Mice; Mice, Knockout; Mitochondria; Renal Insufficiency; Tyrosine | 2012 |
Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species.
Topics: Animals; Antioxidants; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Insulin; Lysine; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tyrosine | 2003 |
The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.
Topics: Albuminuria; Animal Population Groups; Animals; Blood Pressure; Collagen; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Glycation End Products, Advanced; Immediate-Early Proteins; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Kidney; Kinetics; Lysine; Models, Biological; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Solubility; Thiazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tyrosine | 2003 |
NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
Topics: Animals; Antioxidants; Biopterins; Diabetic Nephropathies; Gene Expression Regulation, Enzymologic; Kidney Glomerulus; Male; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxides; Tyrosine | 2005 |
Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure: evidence for hydroxyl radical production.
Topics: Aged; Cross-Sectional Studies; Diabetic Nephropathies; Female; Humans; Hydroxyl Radical; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Phenylalanine; Tyrosine | 2005 |
Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress.
Topics: Animals; Anti-Inflammatory Agents; Chemokine CCL2; Collagen Type I; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Eicosapentaenoic Acid; Lipid Peroxidation; Macrophages; Male; Mice; Oxidative Stress; Phenotype; Transforming Growth Factor beta1; Tyrosine | 2006 |
Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
Topics: Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glycation End Products, Advanced; Immunohistochemistry; Laminin; Lysine; Male; Mice; Pyridoxamine; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schiff Bases; Transforming Growth Factor beta1; Tyrosine | 2007 |
Novel inhibitors of glycation and AGE formation.
Topics: Animals; Ascorbic Acid; Body Weight; Butyrates; Cholesterol; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dyslipidemias; Glycation End Products, Advanced; Glycosylation; Hydroxyl Radical; Hypoglycemic Agents; Kidney; Lipid Metabolism; Lipoproteins, LDL; Male; Molecular Structure; Oxidation-Reduction; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Triglycerides; Tyrosine | 2007 |
Hypertension increases pro-oxidant generation and decreases antioxidant defense in the kidney in early diabetes.
Topics: Animals; Antioxidants; Blood Pressure; Diabetic Nephropathies; Female; Glutathione; Hypertension, Renal; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Oxidants; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Superoxides; Tyrosine | 2008 |
Effect of pitavastatin on type 2 diabetes mellitus nephropathy in KK-Ay/Ta mice.
Topics: Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycated Hemoglobin; GTP Cyclohydrolase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Mice; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein Kinase C; Quinolines; RNA, Messenger; Tyrosine | 2008 |
Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy.
Topics: Calcium; Diabetic Nephropathies; DNA; Dose-Response Relationship, Drug; Enzyme Activation; Glomerular Mesangium; Humans; Inositol Phosphates; Mitogens; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase C; Protein Tyrosine Phosphatases; RNA, Messenger; Tetradecanoylphorbol Acetate; Type C Phospholipases; Tyrosine; Vanadates | 1995 |
[Tyrosine phosphorylation of focal adhesion kinase (p125FAK) and paxillin in glomeruli from diabetic rats].
Topics: Animals; Cell Adhesion Molecules; Cytoskeletal Proteins; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glomerular Mesangium; Male; Paxillin; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Tyrosine | 1996 |
Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy.
Topics: Adolescent; Adult; Aged; Child; Diabetic Nephropathies; Female; Humans; Immunohistochemistry; Kidney; Male; Middle Aged; Nitrates; Tyrosine | 2000 |
Activation of renal signaling pathways in db/db mice with type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hyperinsulinism; Kidney Cortex; Liver; MAP Kinase Signaling System; Mice; Mice, Mutant Strains; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, Insulin; Tyrosine | 2001 |
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; Female; Hydrogen Peroxide; Isoquinolines; Kidney; Lipid Peroxidation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphoproteins; Proteinuria; Quinapril; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Superoxides; Tetrahydroisoquinolines; Tetrazoles; Tyrosine | 2002 |